Whartons Jelly Derived Mesenchymal Stem Cells

Around 5 million annual births in eu and 131 million worldwide give a unique opportunity to collect lifesaving wharton s jelly derived mesenchymal stem cells wj msc.

Whartons jelly derived mesenchymal stem cells.

According to the authors of the review these stem cells can be collected during millions of births each year at the time of delivery. Wharton s jelly is therefore a potential source of adult stem cells often collected from cord blood. Thus more research is needed on the isolation and characterization of mesenchymal ste. Evidences that these cells possess therapeutic properties are constantly accumulating.

They are known as regenerative medicine. In a recent study wharton s jelly tissue transplantation has shown to be able to reduce traumatic brain injury and may have therapeutic potential. A recent publication in biomed research international has reviewed the study on the potential benefits of wharton s jelly derived mesenchymal stem cells in treating a variety of diseases. We report a 16 year old boy who was treated with wj mscs in the course of hie due to post cardiopulmonary resuscitation.

Wharton s jelly derived mesenchymal stem cells wj mscs have been introduced as a possible therapy in hypoxic ischemic encephalopathy hie. Wharton s jelly derived mesenchymal stem cells wj mscs have a high proliferation valency and they do not produce teratogen or carcinogen after subsequent transplantation.